Compare Robinhood Markets, Inc. (HOOD) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Robinhood Markets, Inc. vs 10X Genomics Inc — how do they compare? Robinhood Markets, Inc. trades at $109.02 (market cap $96.21B), while 10X Genomics Inc trades at $82.5 (market cap $10.07B). The key difference: Robinhood Markets, Inc. is far larger — about 9.6× 10X Genomics Inc's market cap, and 10X Genomics Inc is trading nearer its 52-week high, Robinhood Markets, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Robinhood Markets, Inc. for 75 Days and 10X Genomics Inc for 92 Days on average.
| HOOD | TXG | |
|---|---|---|
Market Cap | $96.21B | $10.07B |
Volume | 22,572,153 | 5,657,286 |
Sector | Financials | Health |
52-Week High | $152.46 | $97.74 |
52-Week Low | $65.16 | $11.48 |
Typical Hold Time | 75 Days | 92 Days |
Enterprise Value | $102.75B | $9.59B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Robinhood (HOOD) trades at $109.51, down 2.22% on the day, with a bullish technical signal and strong support at $108. The company reported robust 2025 results with $4.47B revenue and $1.88B net income, though valuation ratios like a P/E of 47.35 remain elevated. Recent news highlights expansion into 24/7 stock trading and AI-powered features, signaling growth initiatives.
Outlook is positive with a $137 consensus price target and 77% buy ratings, but high valuation and competitive pressures pose risks. Earnings beat in Q2 2026 and upcoming Q3 results on October 27, 2026, are key catalysts, though regulatory scrutiny and market volatility could impact momentum.
TXG trades at $76.10, down 5.65% on the day, reflecting a bearish technical trend. The company reported revenue of $642.82M for 2025 with a net loss of $43.54M, though it has consistently beaten quarterly EPS estimates. Recent news highlights strong demand for its Atera spatial biology platform and a patent victory. The stock faces resistance near $77 and support at $72.
The outlook is mixed; strong product demand and improving margins offer upside, but persistent losses and high valuation ratios pose risks. Analyst consensus is divided, with a $74.30 price target slightly below the current price, indicating cautious optimism amid execution challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Robinhood Markets, Inc.
Robinhood Markets, Inc. operates a financial services platform. The Company offers brokerage and cash management applications such as stocks, exchange-traded funds, options, and cryptocurrency. Robinhood Markets serves clients in the United States.
Read more on HOOD →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
